{"id":"NCT00113607","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","briefTitle":"An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer","officialTitle":"An Open-Label Multicenter Randomized Phase 3 Study Comparing the Combination of DOXIL/CAELYX and YONDELIS With DOXIL/CAELYX Alone in Subjects With Advanced Relapsed Ovarian Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-04","primaryCompletion":"2010-11","completion":"2010-11","firstPosted":"2005-06-10","resultsPosted":"2013-08-23","lastUpdate":"2014-06-27"},"enrollment":672,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Ovarian Cancer"],"interventions":[{"type":"DRUG","name":"Trabectedin","otherNames":["Yondelis"]},{"type":"DRUG","name":"DOXIL","otherNames":["CAELYX"]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]}],"arms":[{"label":"DOXIL + trabectedin","type":"EXPERIMENTAL"},{"label":"DOXIL","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to compare the progression-free survival (PFS) of the combination of trabectedin + DOXIL with DOXIL monotherapy in patients with ovarian cancer.","primaryOutcome":{"measure":"Progression-Free Survival (PFS): Independent Radiologist Review","timeFrame":"From the date of randomization until the date of disease progression or death, as assessed for approximately 3 years","effectByArm":[{"arm":"DOXIL","deltaMin":5.8,"sd":null},{"arm":"Trabectedin/DOXIL","deltaMin":7.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0190"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":111,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","Chile","China","France","Germany","Hong Kong","Netherlands","Poland","Russia","Singapore","South Korea","Spain","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["37407274","33960681","22765965","22541893"],"seeAlso":["http://www.ncbi.nlm.nih.gov/pubmed/20516432","http://www.ncbi.nlm.nih.gov/pubmed/22541893"]},"adverseEventsSummary":{"seriousAny":{"events":133,"n":333},"commonTop":["Nausea","Neutropenia","Vomiting","Fatigue","Palmar-Plantar Erythrodysaesthesia Syndrome"]}}